Seminars in reproductive medicine最新文献

Impact of Antiphospholipid Syndrome on Reproductive Outcomes: Current Insights and Management Approaches. 抗磷脂综合征对生殖结果的影响：目前的见解和管理方法。

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-10-24 DOI: 10.1055/s-0044-1790225

Lauren He, Catherine Sims

{"title":"Impact of Antiphospholipid Syndrome on Reproductive Outcomes: Current Insights and Management Approaches.","authors":"Lauren He, Catherine Sims","doi":"10.1055/s-0044-1790225","DOIUrl":"10.1055/s-0044-1790225","url":null,"abstract":"Antiphospholipid syndrome (APS) is a disease characterized by the presence of antiphospholipid (aPL) antibodies, thrombosis, and obstetric complications. While patients with APS can have successful pregnancies, many important considerations exist. APS can also cooccur with other systemic autoimmune diseases which can affect pregnancy, particularly systemic lupus erythematosus. This article reviews specific considerations for pregnancy and reproductive health in patients with APS. Similar to other autoimmune diseases, stable or quiescent disease and planning with a rheumatologist and obstetrician prior to conception are vital components of a successful pregnancy. Pregnancy management for patients with aPL antibodies or diagnosis of APS with aspirin and/or anticoagulation depending on disease profile is discussed, as well as the effects of physiologic changes during pregnancy in maternal and fetal outcomes for this population. Given the reproductive span lasts beyond conception through delivery, we include discussions on safe contraception options, the use of assistive reproductive technology, pregnancy termination, menopause, and male fertility. While APS is a relatively rare condition, the effects this disease can have on maternal and fetal outcomes even with available therapies demonstrates the need for more high-quality, evidence-based research.","PeriodicalId":21661,"journal":{"name":"Seminars in reproductive medicine","volume":" ","pages":"197-208"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142507115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Review of Autoimmune Thyroid Diseases and Their Complex Interplay with Female Fertility.

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-12-12 DOI: 10.1055/s-0044-1795160

Lindsay Carafone, Alex J Knutson, Benjamin J Gigliotti

{"title":"A Review of Autoimmune Thyroid Diseases and Their Complex Interplay with Female Fertility.","authors":"Lindsay Carafone, Alex J Knutson, Benjamin J Gigliotti","doi":"10.1055/s-0044-1795160","DOIUrl":"https://doi.org/10.1055/s-0044-1795160","url":null,"abstract":"Hashimoto thyroiditis and Graves' disease are autoimmune thyroid disorders that are common in women of reproductive age and have a complex relationship with female fertility and health of the maternal-fetal dyad. Both hyperthyroidism and hypothyroidism, whether subclinical or overt in severity, directly or indirectly affect nearly every level of the hypothalamic-pituitary-ovary axis, uterine and ovarian function, as well as fetal development from implantation through delivery. Autoimmunity itself also appears to negatively impact both spontaneous and assisted fertility, as well as miscarriage risk, although the mechanism remains unclear, and the presence and magnitude of risk is variable in published literature. While treatment of overt hyperthyroidism and hypothyroidism is unequivocally recommended by professional societies, the impact of treatment on fertility outcomes, and the role of treatment in subclinical thyroid disease is more controversial. Unfortunately, levothyroxine has not been shown to abrogate the risk of subfertility and miscarriage observed in euthyroid thyroid autoantibody positive women.","PeriodicalId":21661,"journal":{"name":"Seminars in reproductive medicine","volume":"42 3","pages":"178-192"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Autoimmunity in Reproduction.

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-12-12 DOI: 10.1055/s-0044-1793830

Erin M Masaba

引用次数: 0

Impact of Systemic Lupus Erythematosus on Conception: Insights into Infertility, Fertility Preservation, Assisted Reproductive Technology, and Pregnancy Outcomes.

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-12-12 DOI: 10.1055/s-0044-1793827

Amanda Moyer, Cuoghi Edens

引用次数: 0

A Review of Celiac Disease and Its Implications on Fertility and Pregnancy. 乳糜泻及其对生育和怀孕的影响综述。

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-10-21 DOI: 10.1055/s-0044-1791703

Alexandra France, Amulya Penmetsa

引用次数: 0

Autoimmunity in Reproduction.

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-12-12 DOI: 10.1055/s-0044-1792088

Kathleen M Hoeger, Terhi T Piltonen

引用次数: 0

Inflammatory Bowel Disease and Reproductive Health: A Focus on Pregnancy Planning and Outcomes. 炎症性肠病与生殖健康：关注怀孕计划和结果。

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-10-11 DOI: 10.1055/s-0044-1791725

Sahaj Mujumdar, Michelle D'Souza, Maisa I Abdalla

引用次数: 0

Rheumatoid Arthritis and Pregnancy: Managing Disease Activity and Fertility Concerns. 类风湿性关节炎与怀孕：管理疾病活动和生育问题。

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-10-28 DOI: 10.1055/s-0044-1790255

Daniele Marcy, JoAnn Zell, M Kristen Demoruelle

引用次数: 0

Type 1 Diabetes and Pregnancy: Challenges in Glycemic Control and Maternal-Fetal Outcomes. 1 型糖尿病与妊娠：血糖控制和母胎结局的挑战。

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-09-01 Epub Date: 2024-10-08 DOI: 10.1055/s-0044-1791704

Tejumola Apata, Dennis Samuel, Laticia Valle, Sarah D Crimmins

{"title":"Type 1 Diabetes and Pregnancy: Challenges in Glycemic Control and Maternal-Fetal Outcomes.","authors":"Tejumola Apata, Dennis Samuel, Laticia Valle, Sarah D Crimmins","doi":"10.1055/s-0044-1791704","DOIUrl":"10.1055/s-0044-1791704","url":null,"abstract":"Managing type 1 diabetes during pregnancy presents significant challenges due to physiological and hormonal changes. These factors contribute to major changes in insulin sensitivity, complicating efforts to achieve and sustain optimal blood glucose levels. Poorly controlled glucose levels during pregnancy can result in diabetic embryopathy and elevate the risks of maternal complications such as hypertensive disorders and diabetic ketoacidosis. Fetal complications may include preterm birth, fetal demise, and admission to neonatal intensive care units. It is essential to recognize that there is no universal approach to managing glycemic control in pregnant women with T1DM and care should be individualized. Effective management requires a multidisciplinary approach involving regular monitoring, adjustments in insulin therapy, dietary modifications, and consistent prenatal care. Continuous glucose monitoring has emerged as a valuable tool for real-time glucose monitoring, facilitating tighter glycemic control. Education and support for self-management are important in addressing these challenges. Future developments in technology and personalized approaches to care show promising potential for advancing diabetes management during pregnancy. This provides a comprehensive overview of current literature on the challenges with the management of T1DM during pregnancy, focusing on its impact on maternal and neonatal outcomes and highlighting effective strategies for achieving optimal glycemic control.","PeriodicalId":21661,"journal":{"name":"Seminars in reproductive medicine","volume":" ","pages":"239-248"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142393064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of Digital Health Interventions on Birth Equity: A Review. 数字健康干预对出生公平的影响：综述。

IF 1.9 3区医学

Seminars in reproductive medicine Pub Date : 2024-06-01 Epub Date: 2024-09-30 DOI: 10.1055/s-0044-1791206

Shannon Malloy

{"title":"Impact of Digital Health Interventions on Birth Equity: A Review.","authors":"Shannon Malloy","doi":"10.1055/s-0044-1791206","DOIUrl":"10.1055/s-0044-1791206","url":null,"abstract":"The rise in smartphone utilization and technology uptake has popularized digital health interventions as a means of supporting healthy pregnancies and optimizing maternal and child health. Digital health interventions include several modalities, such as telemedicine, remote patient monitoring, smartphone applications, web-based interventions, wearables, and health information technology. However, the impact of these interventions on improving maternal and infant health outcomes by race and socioeconomic status to achieve birth equity is unknown. This review summarizes current literature on the impact of digital health interventions on the outcomes of communities of color and lower socioeconomic status in the United States. We demonstrate there is emerging evidence of the impact of digital health interventions on maternal health outcomes, particularly for telemedicine, but evidence specifically focused on assessing outcomes by race and ethnicity and for other modalities, like mHealth apps or wearables, is limited. Digital health interventions may play a part in birth equity initiatives, but should not be considered a standalone solution, and instead should be integrated into other existing efforts to achieve birth equity, like diversifying the clinician workforce, expanding access to high-quality prenatal and postpartum care, or delivering respectful maternity care.","PeriodicalId":21661,"journal":{"name":"Seminars in reproductive medicine","volume":" ","pages":"140-150"},"PeriodicalIF":1.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142353162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0